Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

✍ Scribed by Gnant, M.; Filipits, M.; Greil, R.; Stoeger, H.; Rudas, M.; Bago-Horvath, Z.; Mlineritsch, B.; Kwasny, W.; Knauer, M.; Singer, C.; Jakesz, R.; Dubsky, P.; Fitzal, F.; Bartsch, R.; Steger, G.; Balic, M.; Ressler, S.; Cowens, J. W.; Storhoff, J.; Ferree, S.; Schaper, C.; Liu, S.; Fesl, C.; Nielsen, T. O.

• Book ID: 126155222
• Publisher: Oxford University Press
• Year: 2014
• Tongue: English
• Weight: 201 KB
• Volume: 25
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mdt494